Sepsis: Time to reconsider the concept

被引:76
作者
Carlet, Jean [1 ]
Cohen, Jonathan [2 ]
Calandra, Thierry [3 ]
Opal, Steven M. [4 ,5 ]
Masur, Henry [6 ]
机构
[1] Grp Hosp Paris St Joseph, Intens Care Unit, Dept Infect Dis, Paris, France
[2] Univ Sussex, Brighton & Sussex Med Sch, Falmer, England
[3] CHU Vaudois, Infect Dis Serv, Dept Med, Lausanne, Switzerland
[4] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA
[5] Brown Univ, Mem Hosp Rhode Isl, Div Infect Dis, Pawtucket, RI 02860 USA
[6] NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA
关键词
sepsis; clinical trials; severe infection; trial design;
D O I
10.1097/CCM.0B013E318165B886
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective., To discuss the difficulty in using the concept of sepsis for clinical trials and propose new ways for designing future trials for severe infections. Design: Short position statement. Methods and Main Research: Using a thorough evaluation of the recent literature in the field of severe sepsis and septic shock, the authors challenge the concept of sepsis as used in the past two decades and propose new ideas for designing future trials in this setting. The two main proposals are first to use a systematic assessment of the targeted inflammatory mediators when the study intends to counteract or replace those. mediators (e.g., anti-tumor necrosis factor-et, activated protein C) and, second, to select more homogeneous populations, coming back to "precise infectious diseases," such as severe community-acquired pneumonia, severe peritonitis, or meningitis. Conclusions. The concept of sepsis has been useful to help clinicians to suspect and detect severe infections. Due to a considerable heterogeneity in the patients and type of infections included in the trials performed in the last two decades, it has not been useful in demonstrating the efficacy of new compounds. The authors propose a dramatic change in the design of future trials dealing with severe infections.
引用
收藏
页码:964 / 966
页数:3
相关论文
共 31 条
  • [1] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane, D
    Sébille, V
    Charpentier, C
    Bollaert, PE
    François, B
    Korach, JM
    Capellier, G
    Cohen, Y
    Azoulay, E
    Troché, G
    Chaumet-Riffaut, P
    Bellissant, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871
  • [2] Hemodynamic monitoring in shock and implications for management International Consensus Conference, Paris, France, 27-28 April 2006
    Antonelli, Massimo
    Levy, Mitchell
    Andrews, Peter J. D.
    Chastre, Jean
    Hudson, Leonard D.
    Manthous, Constantine
    Meduri, G. Umberto
    Moreno, Rui P.
    Putensen, Christian
    Stewart, Thomas
    Torres, Antoni
    [J]. INTENSIVE CARE MEDICINE, 2007, 33 (04) : 575 - 590
  • [3] DIVERGENT EFFICACY OF ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA IN INTRAVASCULAR AND PERITONITIS MODELS OF SEPSIS
    BAGBY, GJ
    PLESSALA, KJ
    WILSON, LA
    THOMPSON, JJ
    NELSON, S
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) : 83 - 88
  • [4] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [5] Prescribing indications based on successful clinical trials in sepsis: A difficult exercise
    Carlet, J
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (02) : 525 - 529
  • [6] Compartmentalization of the inflammatory response in sepsis and SIRS
    Cavaillon, Jean-Marc
    Annane, Djillali
    [J]. JOURNAL OF ENDOTOXIN RESEARCH, 2006, 12 (03): : 151 - 170
  • [7] New strategies for clinical trials in patients with sepsis and septic shock
    Cohen, J
    Guyatt, G
    Bernard, GR
    Calandra, T
    Cook, D
    Elbourne, D
    Marshall, J
    Nunn, A
    Opal, S
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (04) : 880 - 886
  • [8] Cohen J, 2004, CRIT CARE MED, V32, P1510, DOI [10.1097/01.CCM.0000129973.13104.2D, 10.1097/01.CCM.0000145917.89975.F5]
  • [9] Microvascular blood flow is altered in patients with sepsis
    De Backer, D
    Creteur, J
    Preiser, JC
    Dubois, MJ
    Vincent, JL
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) : 98 - 104
  • [10] Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
    Dellinger, R. Phillip
    Levy, Mitchell M.
    Carlet, Jean M.
    Bion, Julian
    Parker, Margaret M.
    Jaeschke, Roman
    Reinhart, Konrad
    Angus, Derek C.
    Brun-Buisson, Christian
    Beale, Richard
    Calandra, Thierty
    Dhainaut, Jean-Francois
    Gerlach, Herwig
    Harvey, Maurene
    Marini, John J.
    Marshall, John
    Ranieri, Marco
    Ramsay, Graham
    Sevransky, Jonathan
    Thompson, B. Taylor
    Townsend, Sean
    Vender, Jeffrey S.
    Zimmerman, Janice L.
    Vincent, Jean-Louis
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (01) : 296 - 327